Issue 9/2015
Content (10 Articles)
Addition of bevacizumab to chemotherapy in patients with ovarian cancer: a systematic review and meta-analysis of randomized trials
J. Li, L. Zhou, X. Chen, Y. Ba
Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis
G. Li, Q. Shen, C. Li, D. Li, J. Chen, M. He
The effect of enhanced recovery program for patients undergoing partial laparoscopic hepatectomy of liver cancer
F. He, X. Lin, F. Xie, Y. Huang, R. Yuan
Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations
T. Masuda, H. Imai, T. Kuwako, Y. Miura, R. Yoshino, K. Kaira, K. Shimizu, N. Sunaga, Y. Tomizawa, S. Ishihara, A. Mogi, T. Hisada, K. Minato, A. Takise, R. Saito, M. Yamada
Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case–control studies
Y. W. Ding, X. Gao, D. X. Ye, W. Liu, L. Wu, H. Y. Sun
Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients
J.-H. Deng, J. Deng, D.-H. Shi, X.-N. Ouyang, P.-G. Niu
Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients
Y. Wang, R. Q. Li, Y. Q. Ai, J. Zhang, P. Z. Zhao, Y. F. Li, W. J. He, Y. X. Xia, W. H. Li
Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel
R. Kar, J. K. Palanichamy, A. Banerjee, P. Chattopadhyay, S. K. Jain, N. Singh
A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
J. M. Sepúlveda, C. Belda-Iniesta, M. Gil-Gil, P. Pérez-Segura, A. Berrocal, G. Reynés, O. Gallego, J. Capellades, J. M. Ordoñez, B. La Orden, C. Balañá
RAS status in Korean patients with stage III and IV colorectal cancer
W.-S. Lee, J. N. Lee, J.-H. Baek, Y. H. Park